Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) Net Margin (2020 - 2025)

LifeStance Health (LFST) has disclosed Net Margin for 6 consecutive years, with 3.05% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 524.0% to 3.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.68% through Dec 2025, up 527.0% year-over-year, with the annual reading at 0.68% for FY2025, 527.0% up from the prior year.
  • Net Margin for Q4 2025 was 3.05% at LifeStance Health, up from 0.3% in the prior quarter.
  • The five-year high for Net Margin was 3.05% in Q4 2025, with the low at 69.29% in Q3 2021.
  • Average Net Margin over 5 years is 19.47%, with a median of 16.71% recorded in 2022.
  • The sharpest move saw Net Margin plummeted -6606bps in 2021, then soared 5189bps in 2022.
  • Over 5 years, Net Margin stood at 56.86% in 2021, then soared by 64bps to 20.34% in 2022, then grew by 21bps to 16.02% in 2023, then soared by 86bps to 2.19% in 2024, then skyrocketed by 240bps to 3.05% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 3.05%, 0.3%, and 1.1% for Q4 2025, Q3 2025, and Q2 2025 respectively.